Clinical Study
Multiple Coronary Artery Thrombosis in 5,10-Methylenetetrahydrofolate Reductase Gene Mutation
Table 1
Summary of thrombophilia screening laboratory findings.
| Tests | Results (normal range) |
| Prothrombin time | 10.80 seconds (8.9–11.7) | International normalized ratio (INR) | 0.96 (0.90–1.14) | Activated partial thromboplastin time | 25.7 (24.5–35.2) | Homocysteine (Hcy) | >50 μmol/L (4.00–15.40) | Protein C activity (%) | 122% (72–160) | Protein S activity (%) | 152% (79–183) | Antithrombin III activity | 108.0% (82.0–112.0) | Factor V Leiden mutation | Negative | Prothrombin gene mutation | Negative | Phospholipid (cardiolipin) AB IgG | 1.8 U/mL GPL (0–10) | Phospholipid (cardiolipin) AB IgM | 0.0 U/mL MPL (0–10) | Lupus anticoagulant | Absent |
|
|